immunAware ApS: Financial statements 2018
CVR: 39189135
Source: annual report 2018, Danish Business Authority
19/12/2017 – 31/12/2018
immunAware ApS (CVR 39189135) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 24,983 and a net result of DKK 18,735. Equity in the 2018 report amounted to DKK 151,235. The solvency ratio was 90.3%.
- Gross Profit
- DKK 24,983
- Profit/Loss
- DKK 18,735
- Equity
- DKK 151,235
- Total Assets
- DKK 167,483
- Employees
- 0
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of June 21, 2018, Søren Buus is registered as director of immunAware ApS.
As of June 21, 2018, Anette Stryhn Buus is registered as adm. dir. of immunAware ApS.
As of June 20, 2018, Søren Buus has stepped down as adm. dir. of immunAware ApS.
As of June 20, 2018, Anette Stryhn Buus has stepped down as director of immunAware ApS.
About immunAware ApS
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.